Weed (BUDZ) Liabilities and Shareholders Equity (2010 - 2026)

Weed (BUDZ) recorded quarterly Liabilities and Shareholders Equity of $515713.0 in Q1 2026, down 7.89% quarter-over-quarter from $559906.0 in Q4 2025, and down 10.33% on a YoY basis from $575128.0 in Q1 2025.

Weed (BUDZ) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Weed's Liabilities and Shareholders Equity history runs 13 years deep, the most recent figure standing at $515713.0 for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 10.33% year-over-year to $515713.0; the TTM figure through Mar 2026 stood at $2.2 million (down 14.2% YoY), while the FY2025 annual figure was $559906.0, down 24.17% from the prior year.
  • Liabilities and Shareholders Equity was $515713.0 for Q1 2026 at Weed, down from $559906.0 in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.8 million in Q2 2022 to a low of $515713.0 in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $1.1 million across 5 years, with a median of $738366.0 in 2024.
  • The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity surged 50.73% in 2022, then sank 53.89% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.6 million in 2022, then tumbled by 44.67% to $904062.0 in 2023, then decreased by 18.33% to $738366.0 in 2024, then declined by 24.17% to $559906.0 in 2025, then slipped by 7.89% to $515713.0 in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $515713.0 (Q1 2026), $559906.0 (Q4 2025), and $532267.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Weed - - - 515,713.00

Historic Data

Download Data
DateValue
Mar 31, 2026 515,713.00
Dec 31, 2025 559,906.00
Sep 30, 2025 532,267.00
Jun 30, 2025 548,906.00
Mar 31, 2025 575,128.00
Dec 31, 2024 738,366.00
Sep 30, 2024 596,818.00
Jun 30, 2024 603,296.00
Mar 31, 2024 703,807.00
Dec 31, 2023 904,062.00
Sep 30, 2023 1.28 Mn
Jun 30, 2023 1.31 Mn
Mar 31, 2023 1.40 Mn
Dec 31, 2022 1.63 Mn
Sep 30, 2022 2.44 Mn
Jun 30, 2022 2.77 Mn
Mar 31, 2022 1.94 Mn
Dec 31, 2021 1.96 Mn
Sep 30, 2021 1.81 Mn
Jun 30, 2021 1.84 Mn